Log In
Print this Print this

Pyridorin Intravenous, pyridoxamine

  Manage Alerts
Collapse Summary General Information
Company NephroGenex Inc.
DescriptionIntravenous formulation of Pyridorin, an inhibitor of non-enzymatic glycoxidation leading to advanced glycation end-product (AGE) formation
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRenal damage
Indication DetailsTreat acute kidney injury (AKI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today